New Additions in Biosimilar Elisa Kits

Abbexa is a leader in specialty antibodies, proteins, ELISA kits, and other reagents for life science research. They have made a difference to researchers worldwide by providing excellent-quality products. Based at the world-renowned Cambridge Science Park in Cambridge, UK, they supply and distribute biological tools for the life sciences, pharmaceutical development, and biotechnology sectors. Abbexa provides the scientific community with a wide variety of laboratory tools, including primary antibodies, secondary antibodies, and proteins.

As an exclusive distributor of Abbexa in India, we take pride in announcing the launch of two new ELISA kits for biosimilar antibodies:

Infliximab is a chimeric monoclonal antibody used to treat auto-immune disorders. It reduces the amount of active human tumor necrosis factor (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. Infliximab is used for the treatment of psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.